|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/16 |
| (11) | Patento numeris | 1814573 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05824723.0 |
| Europos patento paraiškos padavimo data | 2005-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-08-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-03-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/039226 |
| Data | 2005-10-31 |
| (87) | Numeris | WO 2006/050247 |
| Data | 2006-05-11 |
| (30) | Numeris | Data | Šalis |
| 623342 P | 2004-10-29 | US |
| (72) |
DEFREES, Shawn, US
|
| (73) |
ratiopharm GmbH,
Graf-Arco-Strasse 3, 89079 Ulm,
DE
|
| (54) | REMODELING AND GLYCOPEGYLATION OF FIBROBLAST GROWTH FACTOR (FGF) |
| REMODELING AND GLYCOPEGYLATION OF FIBROBLAST GROWTH FACTOR (FGF) |